Lupin Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 1.35 Cr
as on 18-12-2024
- Company Age 1 Year 5 Months
- Last Filing with ROC 31 Mar 2024
About Lupin Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Makharia, Rajeev Sibal, and Nilesh Gupta serve as directors at the Company.
- CIN/LLPIN
U86100MH2023PLC406793
- Company No.
406793
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2023
- Date of AGM
15 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lupin Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Gupta  | Director | 17-Jul-2023 | Current |
| Sunil Makharia | Director | 17-Jul-2023 | Current |
| Rajeev Sibal | Director | 17-Jul-2023 | Current |
Financial Performance of Lupin Life Sciences.
Lupin Life Sciences Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lupin Life Sciences?
Unlock access to Lupin Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lupin Digital Health LimitedActive 3 years 7 monthsSunil Makharia, Rajeev Sibal and 1 more are mutual person
Lupin Diagnostics LimitedActive 13 years 9 monthsSunil Makharia, Rajeev Sibal and 1 more are mutual person
Lupin Investments Private LimitedActive 40 years 3 monthsSunil Makharia and Nilesh Gupta are mutual person
Polynova Industries LimitedActive 38 years 2 monthsSunil Makharia and Nilesh Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lupin Life Sciences?
Lupin Life Sciences has a workforce of 0 employees as of Mar 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lupin Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lupin Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
